Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrazines as GPR40 agonists

Substituted pyrazines as GPR40 agonists

US Patent 9688642 · Granted Jun 27, 2017

Estimated economic value: $57,687,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lactic acid bacteria and its applications2024
Set membership testers for aligning nucleic acid samples2022
Cyclohexyl GPR40 agonists for the treatment of type II diabetes2021
Cyclohexyl GPR40 agonists for the treatment of type II diabetes2021
Cyclohexyl GPR40 agonists for the treatment of type II diabetes2021
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2020
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2020
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2018
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2018
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2018
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2018
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2018